Anti-NLN antibodies are used in the immunodetection of the protein neurolysin. In humans, the canonical protein has a reported length of 704 amino acid residues and a mass of 80.7 kDa. Its subcellular localization is in the mitochondria and cytoplasm. It is notably expressed in many tissues, such as the appendix, tonsil, and adrenal gland. A member of the Peptidase M3 protein family, NLN is known to be involved with GPCR signaling pathways and proteolysis. Synonyms for this target antigen include angiotensin binding protein, endopeptidase 24.16, microsomal endopeptidase, mitochondrial oligopeptidase M, neurolysin (metallopeptidase M3 family), and neurolysin, mitochondrial. NLN gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some NLN antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. Flow Cytometry and Immunohistochemistry are also common applications.